Clinical Trial Update: Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial MK-7240-015 evaluating Tulisokibart in adults with psoriatic arthritis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Tulisokibart

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriatic Arthritis | Phase 2 | Status: NOT_YET_RECRUITING